Global Oncology Ablation Device Supply, Demand and Key Producers, 2026-2032
The global Oncology Ablation Device market size is expected to reach $ 5594 million by 2032, rising at a market growth of 10.3% CAGR during the forecast period (2026-2032).
Oncology ablation devices refer to a class of image-guided medical systems that deliver controlled physical energy—such as radiofrequency, microwave, cryoablation, laser, or high-intensity focused ultrasound—to induce localized thermal or cryogenic destruction of tumor tissues. These systems typically consist of energy generators, ablation probes or electrodes, cooling or energy transmission modules, and imaging navigation and control platforms, enabling precise targeting and real-time treatment under CT, ultrasound, or MRI guidance. Widely used in treating solid tumors such as liver, lung, kidney cancers, and bone metastases, they offer advantages including minimal invasiveness, high safety, rapid recovery, and repeatability. With the advancement of precision medicine and minimally invasive therapies, oncology ablation devices are evolving from supportive tools into core equipment in comprehensive cancer treatment systems, increasingly expanding into early-stage curative and outpatient clinical settings.The average gross profit margin of this product is 72%.
With the rising global cancer incidence and improving early screening systems, oncology treatment is shifting from surgery-dominant approaches to minimally invasive precision therapies, driving sustained growth in oncology ablation devices. Corporate reports and investment research highlight continuous advancements in RF, microwave, and cryo technologies, along with upgrades in imaging navigation and digital control platforms, significantly improving device precision and safety. In addition, government-led initiatives promoting tiered healthcare and day-surgery models are accelerating the penetration of minimally invasive devices into primary and specialty care settings, unlocking substantial structural demand.
The industry still faces challenges such as a lack of standardized clinical pathways and the coexistence of multiple technological approaches, leading to variability in treatment outcomes for complex tumors and high reliance on physician expertise and training systems. High R&D and maintenance costs, combined with lagging reimbursement policies and clinical guideline updates, limit adoption in certain regions. Moreover, traditional surgical and radiotherapy systems remain well-established, creating sustained competitive pressure on device substitution.
Clinical practice is shifting toward multidisciplinary, minimally invasive treatment models, with expanding applications of ablation devices in liver cancer, lung nodules, and metastatic tumors. Increasing patient demand for reduced trauma, shorter recovery times, and improved quality of life is driving the growth of outpatient and day-care procedures. Furthermore, the trend toward chronic cancer management is transforming ablation devices from single-use treatment tools into long-term therapeutic platforms, extending replacement cycles and driving sustained demand.
Key upstream components include RF power modules, microwave generators, cryogenic systems, medical-grade metals, and polymer insulation materials, all critical to energy stability and clinical safety. Industry disclosures and investment research indicate that while domestic precision manufacturing capabilities are improving and partial localization of electronic components is underway, high-end sensors and imaging fusion components still rely on imports. The supply chain is rapidly evolving toward platform-based integration, with upstream players expanding from component supply to system-level solutions, enhancing overall value capture and raising technological barriers.
This report studies the global Oncology Ablation Device demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oncology Ablation Device, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oncology Ablation Device that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oncology Ablation Device total market, 2021-2032, (USD Million)
Global Oncology Ablation Device total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Oncology Ablation Device total market, key domestic companies, and share, (USD Million)
Global Oncology Ablation Device revenue by player, revenue and market share 2021-2026, (USD Million)
Global Oncology Ablation Device total market by Energy Source, CAGR, 2021-2032, (USD Million)
Global Oncology Ablation Device total market by Procedure Type, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Oncology Ablation Device market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chongqing Haifu Medical, AngioDynamics, Boston Scientific, Medtronic, Yigao Medical, Haijieya, Beijing Weierfu, Micro Tech Medical, Better Medical, Vison Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Oncology Ablation Device market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Energy Source, and by Procedure Type. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Oncology Ablation Device Market, By Region:
1. How big is the global Oncology Ablation Device market?
2. What is the demand of the global Oncology Ablation Device market?
3. What is the year over year growth of the global Oncology Ablation Device market?
4. What is the total value of the global Oncology Ablation Device market?
5. Who are the Major Players in the global Oncology Ablation Device market?
6. What are the growth factors driving the market demand?
Oncology ablation devices refer to a class of image-guided medical systems that deliver controlled physical energy—such as radiofrequency, microwave, cryoablation, laser, or high-intensity focused ultrasound—to induce localized thermal or cryogenic destruction of tumor tissues. These systems typically consist of energy generators, ablation probes or electrodes, cooling or energy transmission modules, and imaging navigation and control platforms, enabling precise targeting and real-time treatment under CT, ultrasound, or MRI guidance. Widely used in treating solid tumors such as liver, lung, kidney cancers, and bone metastases, they offer advantages including minimal invasiveness, high safety, rapid recovery, and repeatability. With the advancement of precision medicine and minimally invasive therapies, oncology ablation devices are evolving from supportive tools into core equipment in comprehensive cancer treatment systems, increasingly expanding into early-stage curative and outpatient clinical settings.The average gross profit margin of this product is 72%.
With the rising global cancer incidence and improving early screening systems, oncology treatment is shifting from surgery-dominant approaches to minimally invasive precision therapies, driving sustained growth in oncology ablation devices. Corporate reports and investment research highlight continuous advancements in RF, microwave, and cryo technologies, along with upgrades in imaging navigation and digital control platforms, significantly improving device precision and safety. In addition, government-led initiatives promoting tiered healthcare and day-surgery models are accelerating the penetration of minimally invasive devices into primary and specialty care settings, unlocking substantial structural demand.
The industry still faces challenges such as a lack of standardized clinical pathways and the coexistence of multiple technological approaches, leading to variability in treatment outcomes for complex tumors and high reliance on physician expertise and training systems. High R&D and maintenance costs, combined with lagging reimbursement policies and clinical guideline updates, limit adoption in certain regions. Moreover, traditional surgical and radiotherapy systems remain well-established, creating sustained competitive pressure on device substitution.
Clinical practice is shifting toward multidisciplinary, minimally invasive treatment models, with expanding applications of ablation devices in liver cancer, lung nodules, and metastatic tumors. Increasing patient demand for reduced trauma, shorter recovery times, and improved quality of life is driving the growth of outpatient and day-care procedures. Furthermore, the trend toward chronic cancer management is transforming ablation devices from single-use treatment tools into long-term therapeutic platforms, extending replacement cycles and driving sustained demand.
Key upstream components include RF power modules, microwave generators, cryogenic systems, medical-grade metals, and polymer insulation materials, all critical to energy stability and clinical safety. Industry disclosures and investment research indicate that while domestic precision manufacturing capabilities are improving and partial localization of electronic components is underway, high-end sensors and imaging fusion components still rely on imports. The supply chain is rapidly evolving toward platform-based integration, with upstream players expanding from component supply to system-level solutions, enhancing overall value capture and raising technological barriers.
This report studies the global Oncology Ablation Device demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oncology Ablation Device, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oncology Ablation Device that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oncology Ablation Device total market, 2021-2032, (USD Million)
Global Oncology Ablation Device total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Oncology Ablation Device total market, key domestic companies, and share, (USD Million)
Global Oncology Ablation Device revenue by player, revenue and market share 2021-2026, (USD Million)
Global Oncology Ablation Device total market by Energy Source, CAGR, 2021-2032, (USD Million)
Global Oncology Ablation Device total market by Procedure Type, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Oncology Ablation Device market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chongqing Haifu Medical, AngioDynamics, Boston Scientific, Medtronic, Yigao Medical, Haijieya, Beijing Weierfu, Micro Tech Medical, Better Medical, Vison Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Oncology Ablation Device market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Energy Source, and by Procedure Type. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Oncology Ablation Device Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Microwave Ablation
- Radiofrequency Ablation
- Cryoablation
- High-Intensity Focused Ultrasound (HIFU)
- Others
- Liver Cancer
- Lung Cancer
- Breast Cancer
- Other
- Chongqing Haifu Medical
- AngioDynamics
- Boston Scientific
- Medtronic
- Yigao Medical
- Haijieya
- Beijing Weierfu
- Micro Tech Medical
- Better Medical
- Vison Medical
- Shanghai Maide
- HealthTronics
- J &J
- EDAP TMS
- Sonacare Medical
- Misonix
1. How big is the global Oncology Ablation Device market?
2. What is the demand of the global Oncology Ablation Device market?
3. What is the year over year growth of the global Oncology Ablation Device market?
4. What is the total value of the global Oncology Ablation Device market?
5. Who are the Major Players in the global Oncology Ablation Device market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Oncology Ablation Device Introduction
1.2 World Oncology Ablation Device Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Oncology Ablation Device Total Market by Region (by Headquarter Location)
1.3.1 World Oncology Ablation Device Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Oncology Ablation Device Revenue (2021-2032)
1.3.3 China Based Company Oncology Ablation Device Revenue (2021-2032)
1.3.4 Europe Based Company Oncology Ablation Device Revenue (2021-2032)
1.3.5 Japan Based Company Oncology Ablation Device Revenue (2021-2032)
1.3.6 South Korea Based Company Oncology Ablation Device Revenue (2021-2032)
1.3.7 ASEAN Based Company Oncology Ablation Device Revenue (2021-2032)
1.3.8 India Based Company Oncology Ablation Device Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oncology Ablation Device Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Oncology Ablation Device Consumption Value (2021-2032)
2.2 World Oncology Ablation Device Consumption Value by Region
2.2.1 World Oncology Ablation Device Consumption Value by Region (2021-2026)
2.2.2 World Oncology Ablation Device Consumption Value Forecast by Region (2027-2032)
2.3 United States Oncology Ablation Device Consumption Value (2021-2032)
2.4 China Oncology Ablation Device Consumption Value (2021-2032)
2.5 Europe Oncology Ablation Device Consumption Value (2021-2032)
2.6 Japan Oncology Ablation Device Consumption Value (2021-2032)
2.7 South Korea Oncology Ablation Device Consumption Value (2021-2032)
2.8 ASEAN Oncology Ablation Device Consumption Value (2021-2032)
2.9 India Oncology Ablation Device Consumption Value (2021-2032)
3 WORLD ONCOLOGY ABLATION DEVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Oncology Ablation Device Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Oncology Ablation Device Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Oncology Ablation Device in 2025
3.2.3 Global Concentration Ratios (CR8) for Oncology Ablation Device in 2025
3.3 Oncology Ablation Device Company Evaluation Quadrant
3.4 Oncology Ablation Device Market: Overall Company Footprint Analysis
3.4.1 Oncology Ablation Device Market: Region Footprint
3.4.2 Oncology Ablation Device Market: Company Product Type Footprint
3.4.3 Oncology Ablation Device Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Oncology Ablation Device Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Oncology Ablation Device Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Oncology Ablation Device Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Oncology Ablation Device Consumption Value Comparison
4.2.1 United States VS China: Oncology Ablation Device Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Oncology Ablation Device Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Oncology Ablation Device Companies and Market Share, 2021-2026
4.3.1 United States Based Oncology Ablation Device Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Oncology Ablation Device Revenue, (2021-2026)
4.4 China Based Companies Oncology Ablation Device Revenue and Market Share, 2021-2026
4.4.1 China Based Oncology Ablation Device Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Oncology Ablation Device Revenue, (2021-2026)
4.5 Rest of World Based Oncology Ablation Device Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Oncology Ablation Device Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Oncology Ablation Device Revenue (2021-2026)
5 MARKET ANALYSIS BY ENERGY SOURCE
5.1 World Oncology Ablation Device Market Size Overview by Energy Source: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Energy Source
5.2.1 Microwave Ablation
5.2.2 Radiofrequency Ablation
5.2.3 Cryoablation
5.2.4 High-Intensity Focused Ultrasound (HIFU)
5.2.5 Others
5.3 Market Segment by Energy Source
5.3.1 World Oncology Ablation Device Market Size by Energy Source (2021-2026)
5.3.2 World Oncology Ablation Device Market Size by Energy Source (2027-2032)
5.3.3 World Oncology Ablation Device Market Size Market Share by Energy Source (2027-2032)
6 MARKET ANALYSIS BY PROCEDURE TYPE
6.1 World Oncology Ablation Device Market Size Overview by Procedure Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Procedure Type
6.2.1 Liver Cancer
6.2.2 Lung Cancer
6.2.3 Breast Cancer
6.2.4 Other
6.3 Market Segment by Procedure Type
6.3.1 World Oncology Ablation Device Market Size by Procedure Type (2021-2026)
6.3.2 World Oncology Ablation Device Market Size by Procedure Type (2027-2032)
6.3.3 World Oncology Ablation Device Market Size Market Share by Procedure Type (2021-2032)
7 COMPANY PROFILES
7.1 Chongqing Haifu Medical
7.1.1 Chongqing Haifu Medical Details
7.1.2 Chongqing Haifu Medical Major Business
7.1.3 Chongqing Haifu Medical Oncology Ablation Device Product and Services
7.1.4 Chongqing Haifu Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Chongqing Haifu Medical Recent Developments/Updates
7.1.6 Chongqing Haifu Medical Competitive Strengths & Weaknesses
7.2 AngioDynamics
7.2.1 AngioDynamics Details
7.2.2 AngioDynamics Major Business
7.2.3 AngioDynamics Oncology Ablation Device Product and Services
7.2.4 AngioDynamics Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 AngioDynamics Recent Developments/Updates
7.2.6 AngioDynamics Competitive Strengths & Weaknesses
7.3 Boston Scientific
7.3.1 Boston Scientific Details
7.3.2 Boston Scientific Major Business
7.3.3 Boston Scientific Oncology Ablation Device Product and Services
7.3.4 Boston Scientific Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Boston Scientific Recent Developments/Updates
7.3.6 Boston Scientific Competitive Strengths & Weaknesses
7.4 Medtronic
7.4.1 Medtronic Details
7.4.2 Medtronic Major Business
7.4.3 Medtronic Oncology Ablation Device Product and Services
7.4.4 Medtronic Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Medtronic Recent Developments/Updates
7.4.6 Medtronic Competitive Strengths & Weaknesses
7.5 Yigao Medical
7.5.1 Yigao Medical Details
7.5.2 Yigao Medical Major Business
7.5.3 Yigao Medical Oncology Ablation Device Product and Services
7.5.4 Yigao Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Yigao Medical Recent Developments/Updates
7.5.6 Yigao Medical Competitive Strengths & Weaknesses
7.6 Haijieya
7.6.1 Haijieya Details
7.6.2 Haijieya Major Business
7.6.3 Haijieya Oncology Ablation Device Product and Services
7.6.4 Haijieya Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Haijieya Recent Developments/Updates
7.6.6 Haijieya Competitive Strengths & Weaknesses
7.7 Beijing Weierfu
7.7.1 Beijing Weierfu Details
7.7.2 Beijing Weierfu Major Business
7.7.3 Beijing Weierfu Oncology Ablation Device Product and Services
7.7.4 Beijing Weierfu Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Beijing Weierfu Recent Developments/Updates
7.7.6 Beijing Weierfu Competitive Strengths & Weaknesses
7.8 Micro Tech Medical
7.8.1 Micro Tech Medical Details
7.8.2 Micro Tech Medical Major Business
7.8.3 Micro Tech Medical Oncology Ablation Device Product and Services
7.8.4 Micro Tech Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Micro Tech Medical Recent Developments/Updates
7.8.6 Micro Tech Medical Competitive Strengths & Weaknesses
7.9 Better Medical
7.9.1 Better Medical Details
7.9.2 Better Medical Major Business
7.9.3 Better Medical Oncology Ablation Device Product and Services
7.9.4 Better Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Better Medical Recent Developments/Updates
7.9.6 Better Medical Competitive Strengths & Weaknesses
7.10 Vison Medical
7.10.1 Vison Medical Details
7.10.2 Vison Medical Major Business
7.10.3 Vison Medical Oncology Ablation Device Product and Services
7.10.4 Vison Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Vison Medical Recent Developments/Updates
7.10.6 Vison Medical Competitive Strengths & Weaknesses
7.11 Shanghai Maide
7.11.1 Shanghai Maide Details
7.11.2 Shanghai Maide Major Business
7.11.3 Shanghai Maide Oncology Ablation Device Product and Services
7.11.4 Shanghai Maide Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Shanghai Maide Recent Developments/Updates
7.11.6 Shanghai Maide Competitive Strengths & Weaknesses
7.12 HealthTronics
7.12.1 HealthTronics Details
7.12.2 HealthTronics Major Business
7.12.3 HealthTronics Oncology Ablation Device Product and Services
7.12.4 HealthTronics Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 HealthTronics Recent Developments/Updates
7.12.6 HealthTronics Competitive Strengths & Weaknesses
7.13 J &J
7.13.1 J &J Details
7.13.2 J &J Major Business
7.13.3 J &J Oncology Ablation Device Product and Services
7.13.4 J &J Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 J &J Recent Developments/Updates
7.13.6 J &J Competitive Strengths & Weaknesses
7.14 EDAP TMS
7.14.1 EDAP TMS Details
7.14.2 EDAP TMS Major Business
7.14.3 EDAP TMS Oncology Ablation Device Product and Services
7.14.4 EDAP TMS Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 EDAP TMS Recent Developments/Updates
7.14.6 EDAP TMS Competitive Strengths & Weaknesses
7.15 Sonacare Medical
7.15.1 Sonacare Medical Details
7.15.2 Sonacare Medical Major Business
7.15.3 Sonacare Medical Oncology Ablation Device Product and Services
7.15.4 Sonacare Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.15.5 Sonacare Medical Recent Developments/Updates
7.15.6 Sonacare Medical Competitive Strengths & Weaknesses
7.16 Misonix
7.16.1 Misonix Details
7.16.2 Misonix Major Business
7.16.3 Misonix Oncology Ablation Device Product and Services
7.16.4 Misonix Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.16.5 Misonix Recent Developments/Updates
7.16.6 Misonix Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Oncology Ablation Device Industry Chain
8.2 Oncology Ablation Device Upstream Analysis
8.3 Oncology Ablation Device Midstream Analysis
8.4 Oncology Ablation Device Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Oncology Ablation Device Introduction
1.2 World Oncology Ablation Device Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Oncology Ablation Device Total Market by Region (by Headquarter Location)
1.3.1 World Oncology Ablation Device Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Oncology Ablation Device Revenue (2021-2032)
1.3.3 China Based Company Oncology Ablation Device Revenue (2021-2032)
1.3.4 Europe Based Company Oncology Ablation Device Revenue (2021-2032)
1.3.5 Japan Based Company Oncology Ablation Device Revenue (2021-2032)
1.3.6 South Korea Based Company Oncology Ablation Device Revenue (2021-2032)
1.3.7 ASEAN Based Company Oncology Ablation Device Revenue (2021-2032)
1.3.8 India Based Company Oncology Ablation Device Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oncology Ablation Device Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Oncology Ablation Device Consumption Value (2021-2032)
2.2 World Oncology Ablation Device Consumption Value by Region
2.2.1 World Oncology Ablation Device Consumption Value by Region (2021-2026)
2.2.2 World Oncology Ablation Device Consumption Value Forecast by Region (2027-2032)
2.3 United States Oncology Ablation Device Consumption Value (2021-2032)
2.4 China Oncology Ablation Device Consumption Value (2021-2032)
2.5 Europe Oncology Ablation Device Consumption Value (2021-2032)
2.6 Japan Oncology Ablation Device Consumption Value (2021-2032)
2.7 South Korea Oncology Ablation Device Consumption Value (2021-2032)
2.8 ASEAN Oncology Ablation Device Consumption Value (2021-2032)
2.9 India Oncology Ablation Device Consumption Value (2021-2032)
3 WORLD ONCOLOGY ABLATION DEVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Oncology Ablation Device Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Oncology Ablation Device Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Oncology Ablation Device in 2025
3.2.3 Global Concentration Ratios (CR8) for Oncology Ablation Device in 2025
3.3 Oncology Ablation Device Company Evaluation Quadrant
3.4 Oncology Ablation Device Market: Overall Company Footprint Analysis
3.4.1 Oncology Ablation Device Market: Region Footprint
3.4.2 Oncology Ablation Device Market: Company Product Type Footprint
3.4.3 Oncology Ablation Device Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Oncology Ablation Device Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Oncology Ablation Device Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Oncology Ablation Device Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Oncology Ablation Device Consumption Value Comparison
4.2.1 United States VS China: Oncology Ablation Device Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Oncology Ablation Device Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Oncology Ablation Device Companies and Market Share, 2021-2026
4.3.1 United States Based Oncology Ablation Device Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Oncology Ablation Device Revenue, (2021-2026)
4.4 China Based Companies Oncology Ablation Device Revenue and Market Share, 2021-2026
4.4.1 China Based Oncology Ablation Device Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Oncology Ablation Device Revenue, (2021-2026)
4.5 Rest of World Based Oncology Ablation Device Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Oncology Ablation Device Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Oncology Ablation Device Revenue (2021-2026)
5 MARKET ANALYSIS BY ENERGY SOURCE
5.1 World Oncology Ablation Device Market Size Overview by Energy Source: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Energy Source
5.2.1 Microwave Ablation
5.2.2 Radiofrequency Ablation
5.2.3 Cryoablation
5.2.4 High-Intensity Focused Ultrasound (HIFU)
5.2.5 Others
5.3 Market Segment by Energy Source
5.3.1 World Oncology Ablation Device Market Size by Energy Source (2021-2026)
5.3.2 World Oncology Ablation Device Market Size by Energy Source (2027-2032)
5.3.3 World Oncology Ablation Device Market Size Market Share by Energy Source (2027-2032)
6 MARKET ANALYSIS BY PROCEDURE TYPE
6.1 World Oncology Ablation Device Market Size Overview by Procedure Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Procedure Type
6.2.1 Liver Cancer
6.2.2 Lung Cancer
6.2.3 Breast Cancer
6.2.4 Other
6.3 Market Segment by Procedure Type
6.3.1 World Oncology Ablation Device Market Size by Procedure Type (2021-2026)
6.3.2 World Oncology Ablation Device Market Size by Procedure Type (2027-2032)
6.3.3 World Oncology Ablation Device Market Size Market Share by Procedure Type (2021-2032)
7 COMPANY PROFILES
7.1 Chongqing Haifu Medical
7.1.1 Chongqing Haifu Medical Details
7.1.2 Chongqing Haifu Medical Major Business
7.1.3 Chongqing Haifu Medical Oncology Ablation Device Product and Services
7.1.4 Chongqing Haifu Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.1.5 Chongqing Haifu Medical Recent Developments/Updates
7.1.6 Chongqing Haifu Medical Competitive Strengths & Weaknesses
7.2 AngioDynamics
7.2.1 AngioDynamics Details
7.2.2 AngioDynamics Major Business
7.2.3 AngioDynamics Oncology Ablation Device Product and Services
7.2.4 AngioDynamics Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.2.5 AngioDynamics Recent Developments/Updates
7.2.6 AngioDynamics Competitive Strengths & Weaknesses
7.3 Boston Scientific
7.3.1 Boston Scientific Details
7.3.2 Boston Scientific Major Business
7.3.3 Boston Scientific Oncology Ablation Device Product and Services
7.3.4 Boston Scientific Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.3.5 Boston Scientific Recent Developments/Updates
7.3.6 Boston Scientific Competitive Strengths & Weaknesses
7.4 Medtronic
7.4.1 Medtronic Details
7.4.2 Medtronic Major Business
7.4.3 Medtronic Oncology Ablation Device Product and Services
7.4.4 Medtronic Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.4.5 Medtronic Recent Developments/Updates
7.4.6 Medtronic Competitive Strengths & Weaknesses
7.5 Yigao Medical
7.5.1 Yigao Medical Details
7.5.2 Yigao Medical Major Business
7.5.3 Yigao Medical Oncology Ablation Device Product and Services
7.5.4 Yigao Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.5.5 Yigao Medical Recent Developments/Updates
7.5.6 Yigao Medical Competitive Strengths & Weaknesses
7.6 Haijieya
7.6.1 Haijieya Details
7.6.2 Haijieya Major Business
7.6.3 Haijieya Oncology Ablation Device Product and Services
7.6.4 Haijieya Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.6.5 Haijieya Recent Developments/Updates
7.6.6 Haijieya Competitive Strengths & Weaknesses
7.7 Beijing Weierfu
7.7.1 Beijing Weierfu Details
7.7.2 Beijing Weierfu Major Business
7.7.3 Beijing Weierfu Oncology Ablation Device Product and Services
7.7.4 Beijing Weierfu Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.7.5 Beijing Weierfu Recent Developments/Updates
7.7.6 Beijing Weierfu Competitive Strengths & Weaknesses
7.8 Micro Tech Medical
7.8.1 Micro Tech Medical Details
7.8.2 Micro Tech Medical Major Business
7.8.3 Micro Tech Medical Oncology Ablation Device Product and Services
7.8.4 Micro Tech Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.8.5 Micro Tech Medical Recent Developments/Updates
7.8.6 Micro Tech Medical Competitive Strengths & Weaknesses
7.9 Better Medical
7.9.1 Better Medical Details
7.9.2 Better Medical Major Business
7.9.3 Better Medical Oncology Ablation Device Product and Services
7.9.4 Better Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.9.5 Better Medical Recent Developments/Updates
7.9.6 Better Medical Competitive Strengths & Weaknesses
7.10 Vison Medical
7.10.1 Vison Medical Details
7.10.2 Vison Medical Major Business
7.10.3 Vison Medical Oncology Ablation Device Product and Services
7.10.4 Vison Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.10.5 Vison Medical Recent Developments/Updates
7.10.6 Vison Medical Competitive Strengths & Weaknesses
7.11 Shanghai Maide
7.11.1 Shanghai Maide Details
7.11.2 Shanghai Maide Major Business
7.11.3 Shanghai Maide Oncology Ablation Device Product and Services
7.11.4 Shanghai Maide Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.11.5 Shanghai Maide Recent Developments/Updates
7.11.6 Shanghai Maide Competitive Strengths & Weaknesses
7.12 HealthTronics
7.12.1 HealthTronics Details
7.12.2 HealthTronics Major Business
7.12.3 HealthTronics Oncology Ablation Device Product and Services
7.12.4 HealthTronics Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.12.5 HealthTronics Recent Developments/Updates
7.12.6 HealthTronics Competitive Strengths & Weaknesses
7.13 J &J
7.13.1 J &J Details
7.13.2 J &J Major Business
7.13.3 J &J Oncology Ablation Device Product and Services
7.13.4 J &J Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.13.5 J &J Recent Developments/Updates
7.13.6 J &J Competitive Strengths & Weaknesses
7.14 EDAP TMS
7.14.1 EDAP TMS Details
7.14.2 EDAP TMS Major Business
7.14.3 EDAP TMS Oncology Ablation Device Product and Services
7.14.4 EDAP TMS Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.14.5 EDAP TMS Recent Developments/Updates
7.14.6 EDAP TMS Competitive Strengths & Weaknesses
7.15 Sonacare Medical
7.15.1 Sonacare Medical Details
7.15.2 Sonacare Medical Major Business
7.15.3 Sonacare Medical Oncology Ablation Device Product and Services
7.15.4 Sonacare Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.15.5 Sonacare Medical Recent Developments/Updates
7.15.6 Sonacare Medical Competitive Strengths & Weaknesses
7.16 Misonix
7.16.1 Misonix Details
7.16.2 Misonix Major Business
7.16.3 Misonix Oncology Ablation Device Product and Services
7.16.4 Misonix Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026)
7.16.5 Misonix Recent Developments/Updates
7.16.6 Misonix Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Oncology Ablation Device Industry Chain
8.2 Oncology Ablation Device Upstream Analysis
8.3 Oncology Ablation Device Midstream Analysis
8.4 Oncology Ablation Device Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Oncology Ablation Device Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Oncology Ablation Device Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Oncology Ablation Device Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Oncology Ablation Device Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Oncology Ablation Device Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Oncology Ablation Device Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Oncology Ablation Device Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Oncology Ablation Device Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Oncology Ablation Device Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Oncology Ablation Device Players in 2025
Table 12. World Oncology Ablation Device Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Oncology Ablation Device Company Evaluation Quadrant
Table 14. Head Office of Key Oncology Ablation Device Players
Table 15. Oncology Ablation Device Market: Company Product Type Footprint
Table 16. Oncology Ablation Device Market: Company Product Application Footprint
Table 17. Oncology Ablation Device Mergers & Acquisitions Activity
Table 18. United States VS China Oncology Ablation Device Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Oncology Ablation Device Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Oncology Ablation Device Companies, Headquarters (States, Country)
Table 21. United States Based Companies Oncology Ablation Device Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Oncology Ablation Device Revenue Market Share (2021-2026)
Table 23. China Based Oncology Ablation Device Companies, Headquarters (Province, Country)
Table 24. China Based Companies Oncology Ablation Device Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Oncology Ablation Device Revenue Market Share (2021-2026)
Table 26. Rest of World Based Oncology Ablation Device Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Oncology Ablation Device Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Oncology Ablation Device Revenue Market Share (2021-2026)
Table 29. World Oncology Ablation Device Market Size by Energy Source, (USD Million), 2021 & 2025 & 2032
Table 30. World Oncology Ablation Device Market Size Value by Energy Source (2021-2026) & (USD Million)
Table 31. World Oncology Ablation Device Market Size by Energy Source (2027-2032) & (USD Million)
Table 32. World Oncology Ablation Device Market Size by Procedure Type, (USD Million), 2021 & 2025 & 2032
Table 33. World Oncology Ablation Device Market Size by Procedure Type (2021-2026) & (USD Million)
Table 34. World Oncology Ablation Device Market Size by Procedure Type (2027-2032) & (USD Million)
Table 35. Chongqing Haifu Medical Basic Information, Manufacturing Base and Competitors
Table 36. Chongqing Haifu Medical Major Business
Table 37. Chongqing Haifu Medical Oncology Ablation Device Product and Services
Table 38. Chongqing Haifu Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Chongqing Haifu Medical Recent Developments/Updates
Table 40. Chongqing Haifu Medical Competitive Strengths & Weaknesses
Table 41. AngioDynamics Basic Information, Manufacturing Base and Competitors
Table 42. AngioDynamics Major Business
Table 43. AngioDynamics Oncology Ablation Device Product and Services
Table 44. AngioDynamics Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. AngioDynamics Recent Developments/Updates
Table 46. AngioDynamics Competitive Strengths & Weaknesses
Table 47. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 48. Boston Scientific Major Business
Table 49. Boston Scientific Oncology Ablation Device Product and Services
Table 50. Boston Scientific Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Boston Scientific Recent Developments/Updates
Table 52. Boston Scientific Competitive Strengths & Weaknesses
Table 53. Medtronic Basic Information, Manufacturing Base and Competitors
Table 54. Medtronic Major Business
Table 55. Medtronic Oncology Ablation Device Product and Services
Table 56. Medtronic Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Medtronic Recent Developments/Updates
Table 58. Medtronic Competitive Strengths & Weaknesses
Table 59. Yigao Medical Basic Information, Manufacturing Base and Competitors
Table 60. Yigao Medical Major Business
Table 61. Yigao Medical Oncology Ablation Device Product and Services
Table 62. Yigao Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Yigao Medical Recent Developments/Updates
Table 64. Yigao Medical Competitive Strengths & Weaknesses
Table 65. Haijieya Basic Information, Manufacturing Base and Competitors
Table 66. Haijieya Major Business
Table 67. Haijieya Oncology Ablation Device Product and Services
Table 68. Haijieya Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Haijieya Recent Developments/Updates
Table 70. Haijieya Competitive Strengths & Weaknesses
Table 71. Beijing Weierfu Basic Information, Manufacturing Base and Competitors
Table 72. Beijing Weierfu Major Business
Table 73. Beijing Weierfu Oncology Ablation Device Product and Services
Table 74. Beijing Weierfu Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Beijing Weierfu Recent Developments/Updates
Table 76. Beijing Weierfu Competitive Strengths & Weaknesses
Table 77. Micro Tech Medical Basic Information, Manufacturing Base and Competitors
Table 78. Micro Tech Medical Major Business
Table 79. Micro Tech Medical Oncology Ablation Device Product and Services
Table 80. Micro Tech Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Micro Tech Medical Recent Developments/Updates
Table 82. Micro Tech Medical Competitive Strengths & Weaknesses
Table 83. Better Medical Basic Information, Manufacturing Base and Competitors
Table 84. Better Medical Major Business
Table 85. Better Medical Oncology Ablation Device Product and Services
Table 86. Better Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Better Medical Recent Developments/Updates
Table 88. Better Medical Competitive Strengths & Weaknesses
Table 89. Vison Medical Basic Information, Manufacturing Base and Competitors
Table 90. Vison Medical Major Business
Table 91. Vison Medical Oncology Ablation Device Product and Services
Table 92. Vison Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Vison Medical Recent Developments/Updates
Table 94. Vison Medical Competitive Strengths & Weaknesses
Table 95. Shanghai Maide Basic Information, Manufacturing Base and Competitors
Table 96. Shanghai Maide Major Business
Table 97. Shanghai Maide Oncology Ablation Device Product and Services
Table 98. Shanghai Maide Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Shanghai Maide Recent Developments/Updates
Table 100. Shanghai Maide Competitive Strengths & Weaknesses
Table 101. HealthTronics Basic Information, Manufacturing Base and Competitors
Table 102. HealthTronics Major Business
Table 103. HealthTronics Oncology Ablation Device Product and Services
Table 104. HealthTronics Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. HealthTronics Recent Developments/Updates
Table 106. HealthTronics Competitive Strengths & Weaknesses
Table 107. J &J Basic Information, Manufacturing Base and Competitors
Table 108. J &J Major Business
Table 109. J &J Oncology Ablation Device Product and Services
Table 110. J &J Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. J &J Recent Developments/Updates
Table 112. J &J Competitive Strengths & Weaknesses
Table 113. EDAP TMS Basic Information, Manufacturing Base and Competitors
Table 114. EDAP TMS Major Business
Table 115. EDAP TMS Oncology Ablation Device Product and Services
Table 116. EDAP TMS Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. EDAP TMS Recent Developments/Updates
Table 118. EDAP TMS Competitive Strengths & Weaknesses
Table 119. Sonacare Medical Basic Information, Manufacturing Base and Competitors
Table 120. Sonacare Medical Major Business
Table 121. Sonacare Medical Oncology Ablation Device Product and Services
Table 122. Sonacare Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Sonacare Medical Recent Developments/Updates
Table 124. Sonacare Medical Competitive Strengths & Weaknesses
Table 125. Misonix Basic Information, Manufacturing Base and Competitors
Table 126. Misonix Major Business
Table 127. Misonix Oncology Ablation Device Product and Services
Table 128. Misonix Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Misonix Recent Developments/Updates
Table 130. Misonix Competitive Strengths & Weaknesses
Table 131. Global Key Players of Oncology Ablation Device Upstream (Raw Materials)
Table 132. Global Oncology Ablation Device Typical Customers
Table 1. World Oncology Ablation Device Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Oncology Ablation Device Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Oncology Ablation Device Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Oncology Ablation Device Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Oncology Ablation Device Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Oncology Ablation Device Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Oncology Ablation Device Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Oncology Ablation Device Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Oncology Ablation Device Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Oncology Ablation Device Players in 2025
Table 12. World Oncology Ablation Device Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Oncology Ablation Device Company Evaluation Quadrant
Table 14. Head Office of Key Oncology Ablation Device Players
Table 15. Oncology Ablation Device Market: Company Product Type Footprint
Table 16. Oncology Ablation Device Market: Company Product Application Footprint
Table 17. Oncology Ablation Device Mergers & Acquisitions Activity
Table 18. United States VS China Oncology Ablation Device Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Oncology Ablation Device Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Oncology Ablation Device Companies, Headquarters (States, Country)
Table 21. United States Based Companies Oncology Ablation Device Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Oncology Ablation Device Revenue Market Share (2021-2026)
Table 23. China Based Oncology Ablation Device Companies, Headquarters (Province, Country)
Table 24. China Based Companies Oncology Ablation Device Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Oncology Ablation Device Revenue Market Share (2021-2026)
Table 26. Rest of World Based Oncology Ablation Device Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Oncology Ablation Device Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Oncology Ablation Device Revenue Market Share (2021-2026)
Table 29. World Oncology Ablation Device Market Size by Energy Source, (USD Million), 2021 & 2025 & 2032
Table 30. World Oncology Ablation Device Market Size Value by Energy Source (2021-2026) & (USD Million)
Table 31. World Oncology Ablation Device Market Size by Energy Source (2027-2032) & (USD Million)
Table 32. World Oncology Ablation Device Market Size by Procedure Type, (USD Million), 2021 & 2025 & 2032
Table 33. World Oncology Ablation Device Market Size by Procedure Type (2021-2026) & (USD Million)
Table 34. World Oncology Ablation Device Market Size by Procedure Type (2027-2032) & (USD Million)
Table 35. Chongqing Haifu Medical Basic Information, Manufacturing Base and Competitors
Table 36. Chongqing Haifu Medical Major Business
Table 37. Chongqing Haifu Medical Oncology Ablation Device Product and Services
Table 38. Chongqing Haifu Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 39. Chongqing Haifu Medical Recent Developments/Updates
Table 40. Chongqing Haifu Medical Competitive Strengths & Weaknesses
Table 41. AngioDynamics Basic Information, Manufacturing Base and Competitors
Table 42. AngioDynamics Major Business
Table 43. AngioDynamics Oncology Ablation Device Product and Services
Table 44. AngioDynamics Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. AngioDynamics Recent Developments/Updates
Table 46. AngioDynamics Competitive Strengths & Weaknesses
Table 47. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 48. Boston Scientific Major Business
Table 49. Boston Scientific Oncology Ablation Device Product and Services
Table 50. Boston Scientific Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Boston Scientific Recent Developments/Updates
Table 52. Boston Scientific Competitive Strengths & Weaknesses
Table 53. Medtronic Basic Information, Manufacturing Base and Competitors
Table 54. Medtronic Major Business
Table 55. Medtronic Oncology Ablation Device Product and Services
Table 56. Medtronic Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Medtronic Recent Developments/Updates
Table 58. Medtronic Competitive Strengths & Weaknesses
Table 59. Yigao Medical Basic Information, Manufacturing Base and Competitors
Table 60. Yigao Medical Major Business
Table 61. Yigao Medical Oncology Ablation Device Product and Services
Table 62. Yigao Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Yigao Medical Recent Developments/Updates
Table 64. Yigao Medical Competitive Strengths & Weaknesses
Table 65. Haijieya Basic Information, Manufacturing Base and Competitors
Table 66. Haijieya Major Business
Table 67. Haijieya Oncology Ablation Device Product and Services
Table 68. Haijieya Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Haijieya Recent Developments/Updates
Table 70. Haijieya Competitive Strengths & Weaknesses
Table 71. Beijing Weierfu Basic Information, Manufacturing Base and Competitors
Table 72. Beijing Weierfu Major Business
Table 73. Beijing Weierfu Oncology Ablation Device Product and Services
Table 74. Beijing Weierfu Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Beijing Weierfu Recent Developments/Updates
Table 76. Beijing Weierfu Competitive Strengths & Weaknesses
Table 77. Micro Tech Medical Basic Information, Manufacturing Base and Competitors
Table 78. Micro Tech Medical Major Business
Table 79. Micro Tech Medical Oncology Ablation Device Product and Services
Table 80. Micro Tech Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Micro Tech Medical Recent Developments/Updates
Table 82. Micro Tech Medical Competitive Strengths & Weaknesses
Table 83. Better Medical Basic Information, Manufacturing Base and Competitors
Table 84. Better Medical Major Business
Table 85. Better Medical Oncology Ablation Device Product and Services
Table 86. Better Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Better Medical Recent Developments/Updates
Table 88. Better Medical Competitive Strengths & Weaknesses
Table 89. Vison Medical Basic Information, Manufacturing Base and Competitors
Table 90. Vison Medical Major Business
Table 91. Vison Medical Oncology Ablation Device Product and Services
Table 92. Vison Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Vison Medical Recent Developments/Updates
Table 94. Vison Medical Competitive Strengths & Weaknesses
Table 95. Shanghai Maide Basic Information, Manufacturing Base and Competitors
Table 96. Shanghai Maide Major Business
Table 97. Shanghai Maide Oncology Ablation Device Product and Services
Table 98. Shanghai Maide Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Shanghai Maide Recent Developments/Updates
Table 100. Shanghai Maide Competitive Strengths & Weaknesses
Table 101. HealthTronics Basic Information, Manufacturing Base and Competitors
Table 102. HealthTronics Major Business
Table 103. HealthTronics Oncology Ablation Device Product and Services
Table 104. HealthTronics Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. HealthTronics Recent Developments/Updates
Table 106. HealthTronics Competitive Strengths & Weaknesses
Table 107. J &J Basic Information, Manufacturing Base and Competitors
Table 108. J &J Major Business
Table 109. J &J Oncology Ablation Device Product and Services
Table 110. J &J Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. J &J Recent Developments/Updates
Table 112. J &J Competitive Strengths & Weaknesses
Table 113. EDAP TMS Basic Information, Manufacturing Base and Competitors
Table 114. EDAP TMS Major Business
Table 115. EDAP TMS Oncology Ablation Device Product and Services
Table 116. EDAP TMS Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. EDAP TMS Recent Developments/Updates
Table 118. EDAP TMS Competitive Strengths & Weaknesses
Table 119. Sonacare Medical Basic Information, Manufacturing Base and Competitors
Table 120. Sonacare Medical Major Business
Table 121. Sonacare Medical Oncology Ablation Device Product and Services
Table 122. Sonacare Medical Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Sonacare Medical Recent Developments/Updates
Table 124. Sonacare Medical Competitive Strengths & Weaknesses
Table 125. Misonix Basic Information, Manufacturing Base and Competitors
Table 126. Misonix Major Business
Table 127. Misonix Oncology Ablation Device Product and Services
Table 128. Misonix Oncology Ablation Device Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Misonix Recent Developments/Updates
Table 130. Misonix Competitive Strengths & Weaknesses
Table 131. Global Key Players of Oncology Ablation Device Upstream (Raw Materials)
Table 132. Global Oncology Ablation Device Typical Customers
LIST OF FIGURES
Figure 1. Oncology Ablation Device Picture
Figure 2. World Oncology Ablation Device Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Oncology Ablation Device Total Revenue (2021-2032) & (USD Million)
Figure 4. World Oncology Ablation Device Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Oncology Ablation Device Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 13. Oncology Ablation Device Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 16. World Oncology Ablation Device Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 18. China Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 23. India Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Oncology Ablation Device by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Oncology Ablation Device Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Oncology Ablation Device Markets in 2025
Figure 27. United States VS China: Oncology Ablation Device Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Oncology Ablation Device Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Oncology Ablation Device Market Size by Energy Source, (USD Million), 2021 & 2025 & 2032
Figure 30. World Oncology Ablation Device Market Size Market Share by Energy Source in 2025
Figure 31. Microwave Ablation
Figure 32. Radiofrequency Ablation
Figure 33. Cryoablation
Figure 34. High-Intensity Focused Ultrasound (HIFU)
Figure 35. Others
Figure 36. World Oncology Ablation Device Market Size Market Share by Energy Source (2021-2032)
Figure 37. Thermal
Figure 38. Cryogenic
Figure 39. Percutaneous
Figure 40. Laparoscopic
Figure 41. Open
Figure 42. World Oncology Ablation Device Market Size by Procedure Type, (USD Million), 2021 & 2025 & 2032
Figure 43. World Oncology Ablation Device Market Size Market Share by Procedure Type in 2025
Figure 44. Liver Cancer
Figure 45. Lung Cancer
Figure 46. Breast Cancer
Figure 47. Other
Figure 48. World Oncology Ablation Device Market Size Market Share by Procedure Type (2021-2032)
Figure 49. Oncology Ablation Device Industrial Chain
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. Oncology Ablation Device Picture
Figure 2. World Oncology Ablation Device Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Oncology Ablation Device Total Revenue (2021-2032) & (USD Million)
Figure 4. World Oncology Ablation Device Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Oncology Ablation Device Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Oncology Ablation Device Revenue (2021-2032) & (USD Million)
Figure 13. Oncology Ablation Device Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 16. World Oncology Ablation Device Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 18. China Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 23. India Oncology Ablation Device Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Oncology Ablation Device by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Oncology Ablation Device Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Oncology Ablation Device Markets in 2025
Figure 27. United States VS China: Oncology Ablation Device Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Oncology Ablation Device Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Oncology Ablation Device Market Size by Energy Source, (USD Million), 2021 & 2025 & 2032
Figure 30. World Oncology Ablation Device Market Size Market Share by Energy Source in 2025
Figure 31. Microwave Ablation
Figure 32. Radiofrequency Ablation
Figure 33. Cryoablation
Figure 34. High-Intensity Focused Ultrasound (HIFU)
Figure 35. Others
Figure 36. World Oncology Ablation Device Market Size Market Share by Energy Source (2021-2032)
Figure 37. Thermal
Figure 38. Cryogenic
Figure 39. Percutaneous
Figure 40. Laparoscopic
Figure 41. Open
Figure 42. World Oncology Ablation Device Market Size by Procedure Type, (USD Million), 2021 & 2025 & 2032
Figure 43. World Oncology Ablation Device Market Size Market Share by Procedure Type in 2025
Figure 44. Liver Cancer
Figure 45. Lung Cancer
Figure 46. Breast Cancer
Figure 47. Other
Figure 48. World Oncology Ablation Device Market Size Market Share by Procedure Type (2021-2032)
Figure 49. Oncology Ablation Device Industrial Chain
Figure 50. Methodology
Figure 51. Research Process and Data Source
